From the editor: Transition of leadership for JCL.
Publication
, Journal Article
Guyton, JR
Published in: J Clin Lipidol
2023
Duke Scholars
Published In
J Clin Lipidol
DOI
ISSN
1933-2874
Publication Date
2023
Volume
17
Issue
3
Start / End Page
307 / 308
Location
United States
Related Subject Headings
- Leadership
- Humans
- Cardiovascular System & Hematology
- 3205 Medical biochemistry and metabolomics
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
- 1101 Medical Biochemistry and Metabolomics
Citation
APA
Chicago
ICMJE
MLA
NLM
Guyton, J. R. (2023). From the editor: Transition of leadership for JCL. J Clin Lipidol, 17(3), 307–308. https://doi.org/10.1016/j.jacl.2023.05.102
Guyton, John R. “From the editor: Transition of leadership for JCL.” J Clin Lipidol 17, no. 3 (2023): 307–8. https://doi.org/10.1016/j.jacl.2023.05.102.
Guyton JR. From the editor: Transition of leadership for JCL. J Clin Lipidol. 2023;17(3):307–8.
Guyton, John R. “From the editor: Transition of leadership for JCL.” J Clin Lipidol, vol. 17, no. 3, 2023, pp. 307–08. Pubmed, doi:10.1016/j.jacl.2023.05.102.
Guyton JR. From the editor: Transition of leadership for JCL. J Clin Lipidol. 2023;17(3):307–308.
Published In
J Clin Lipidol
DOI
ISSN
1933-2874
Publication Date
2023
Volume
17
Issue
3
Start / End Page
307 / 308
Location
United States
Related Subject Headings
- Leadership
- Humans
- Cardiovascular System & Hematology
- 3205 Medical biochemistry and metabolomics
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
- 1101 Medical Biochemistry and Metabolomics